05.01.2024 - Madryn Asset Management, LP (collectively with its affiliates, “Madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of SomaLogic, Inc. (“SomaLogic” or the “Company”) (Nasdaq: SLGC), is demanding the Company finally . Seite 1
23.12.2023 - Madryn Asset Management, LP (“Madryn Asset Management” and, collectively with its affiliates, “Madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of SomaLogic, Inc. (“SomaLogic” or the “Company”) (Nasdaq: SLGC), today . Seite 1
23.12.2023 - Company Urges Stockholders to Vote “FOR” Value Maximizing Transaction at Upcoming Special MeetingBOULDER, Colo., Dec. 22, 2023 (GLOBE NEWSWIRE) - SomaLogic, Inc., a leader in proteomics technology, today announced that Institutional Shareholder . Seite 1
01.11.2023 - Expanded menu gives researchers broadest coverage of the proteome for increased discovery of biomarkers and drug targetsBOULDER, Colo., Nov. 01, 2023 (GLOBE NEWSWIRE) - SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, . Seite 1
31.10.2023 - BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) - SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the third quarter 2023 after market close on November 8, 2023. Management will host a .